This event is hosted by Johns Hopkins Carey Business School and HBHI
Join us for a thought-provoking panel discussion on improving the policy relevance of academic health economic research, with an emphasis on selecting appropriate methods for the specific question/context.
Panelists
Chapin White, Director of Health Analysis, CBO
Chapin White is a health economist who joined CBO in 2004 and then worked at the Rand Corporation and the Center for Studying Health System Change before rejoining CBO in 2020. His areas of expertise include price transparency, health insurance coverage, provider payment policy, surprise billing, and microsimulation modeling. He holds an A.B. from Harvard College, an M.P.P. from the Harvard Kennedy School, and a Ph.D. in health policy from Harvard University.
Meena Seshamani, MD, PhD, Deputy Administrator and Director, CMS
Meena Seshamani, MD, PhD is an accomplished, strategic leader with a deep understanding of health economics and a heart-felt commitment to outstanding patient care. Her diverse background as a health care executive, health economist, physician and health policy expert has given her a unique perspective on how health policy impacts the real lives of patients. Dr. Seshamani brings decades of policy experience to her role, including recently serving on the leadership of the Biden-Harris Transition HHS Agency Review Team. She also was Director of the Office of Health Reform at the US Department of Health and Human Services, where she drove strategy and led implementation of the Affordable Care Act across the Department, including coverage policy, delivery system reform, and public health policy.
Tom Buchmueller, Deputy Assistant Secretary, ASPE, HHS and Professor, Michigan Ross
Dr. Buchmueller is a health economist whose research focuses mainly on economic and policy issues related to health insurance, including the relationship between health insurance and the labor market, the regulation of health insurance markets, disparities in health insurance coverage and access to care and health care reform. Prior to joining the Michigan faculty in 2007, Dr. Buchmueller taught at the University of California-Irvine. He has held visiting positions at INSEAD, the University of Technology-Sydney, The University of Bordeaux and the University of Southern California. He received his PhD from the University of Wisconsin-Madison and his bachelor’s degree from Carleton College.
Marta Wosińska, PhD, Senior Fellow, Brookings
Marta E. Wosińska, Ph.D., is a senior fellow at the Center on Health Policy. She is a healthcare economist with a particular expertise in prescription drugs and experience spanning academia and federal government. Dr. Wosińska’s government experience includes serving as director of the Bureau of Economics at the Federal Trade Commission, chief healthcare economist in the Office of Inspector General (OIG) at the U.S. Department of Health and Human Services, and director of economics staff at the U.S. Food and Drug Administration (FDA) Center for Drug Evaluation &Research. Dr. Wosińska also served as economic advisor to the U.S. Senate Finance Committee, providing drug market analysis and expert guidance for the Committee’s bipartisan investigative and legislative work on drug pricing.